2/ An early transmission report of suggested transmission is possible prior to symptom onset.

Need to distinguish between: persistently asymptomatic infection (no symptoms attributable to the virus for the duration of infection) and presymptomatic state

https://www.nejm.org/doi/full/10.1056/NEJMc2001468
3/ Inconsistent symptom assessment & reporting has limited defining this group

Our understanding of the possible clinical presentations has evolved since the beginning

Example: anomia/dysgeusia were described in March & increasingly reported after being featured by the media
4/ Many studies have inadequate follow up time to rule out presymptomatic state

Three studies including pregnant women in New York City reported different asymptomatic fractions depending on the follow up period
5/ There may be problems w using seroprevalence studies to assess the asymptomatic fraction since antibody titers may wane faster in asymptomatic individuals compared with symptomatic ones & antibody test characteristics are defined for individuals with PCR-positive infection
6/ Defining the persistently asymptomatic fraction is essential to determining their true transmission potential, which is believed to be lower than those who are symptomatic.

Additionally, defining this group might help illuminate the COVID-19 severity spectrum
7/ To define this group we make 6 recommendations

1st: "asymptomatic" should be reserved for individuals without symptoms throughout duration of infection
8/ 2nd: we need a standardized, broad symptom definition. See differences in table. Canadian definition is most broad.

Note that recent studies have suggested there may be other important symptoms to add including chest pain/pressure https://twitter.com/EricMeyerowitz/status/1326657685308248070?s=20
9/ 3rd: ensure adequate follow up, prospective & retrospective symptom assessment

4th: report testing methodology & protocols so studies can be interpreted & considered in systematic reviews

5th: report details of serologic assays and timing of testing in relation to infection
10/ 6th design studies that minimize ascertainment bias.

Importantly - it is clear that individuals without symptoms or with minimal symptoms can and do transmit SARS-CoV-2 and public health measures need to continue to keep this critical fact in mind
11/ The best and most effective way to truly define the asymptomatic fraction is through systematic reviews.

This review suggests a fraction of 20% (95% confidence interval 17%–25%)

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003346
13/ A great thread from @mugecevik with additional thoughts on asymptomatic infection here https://twitter.com/mugecevik/status/1334830995187576833?s=20
14/ This was a fantastic (and fun) collaboration with the amazing @AaronRichterman @BogochIsaac @nicolamlow @mugecevik 🙏🙏🙏🙏

Thank you to @TheLancetInfDis
15/ Oh and this absolutely fantastic analysis from researchers from NBA season suggests viral shedding may be shorter in duration for asymptomatic individuals

https://www.medrxiv.org/content/10.1101/2020.10.21.20217042v2
You can follow @EricMeyerowitz.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.